Mass spectrometric methods for the analysis of chlorinated and nitrated isoflavonoids: A novel class of biological metabolites

Journal of Mass Spectrometry

Volumn 38, Issue 7, 2003, Pages 764-771

  Prasain, Jeevan K ^a,c   Patel, Rakesh ^b,c   Kirk, Marion ^c   Wilson, Landon ^c   Botting, Nigel ^d   Darley Usmar, Victor M ^b,c   Barnes, Stephen ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Chlorinated isoflavones; Electrospray ionization; Identification; Nitration; Tandem mass spectrometry

Indexed keywords

CELLS; DISSOCIATION; ISOMERS; MASS SPECTROMETRY;

INFLAMMATORY CELLS;

METABOLITES;

3' CHLORODAIDZEIN; 3' CHLOROGENISTEIN; 3' NITRODAIDZEIN; 3' NITROGENISTEIN; 3',8 DICHLORODAIDZEIN; 8 CHLORODAIDZEIN; BIOCHANIN A; DAIDZEIN; DRUG METABOLITE; GENISTEIN; HYDROXYL GROUP; ISOFLAVONOID; NITRO DERIVATIVE; NITROUS ACID; PROTON; PRUNETIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CELL CULTURE; CHLORINATION; CONTROLLED STUDY; DISSOCIATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; ISOMER; MASS SPECTROMETRY; NITRATION; PRIORITY JOURNAL; PROTON TRANSPORT; STANDARD; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

CHLORINE; GENISTEIN; HL-60 CELLS; HUMANS; ISOFLAVONES; NITRATES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0041698331     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.492     Document Type: Article

References (30)

1. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998; 141: 1.
2. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 1998; 356: 1.
3. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J. Biol. Chem. 1995; 270: 16 542.
4. Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 1997; 99: 2075.
5. Daugherty A, Dunn JL, Ratery DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 1994; 94: 437.
6. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 1994; 375: 81.
7. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994; 350: 9.
8. Kettle AJ, Winterbourn CC. Superoxide enhances hypochlorous acid production by stimulated human neutrophils. Biochim. Biophys. Acta 1990; 1052: 379.
9. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite-the good, the bad, and the ugly. Am. J. Phys. 1996; 271: C1424.
10. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (London) 1998; 391: 393.
11. Coward L, Barnes NC, Setchell KDR, Barnes S. The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J. Agric. Food Chem. 1993; 41: 1961.
12. Howes JB, Sullivan D, Lai N, Nestel P, Pomeroy S, West L, Eden JA, Howes LG. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 2000; 152: 143.
13. Messina M, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of in vitro and in vivo data. Nutr. Cancer 1994; 21: 113.
14. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal US. women: the Framingham study. J. Nutr. 2002; 132: 276.
15. Barnes S. In Functional Foods 2000, Angus F, Miller C (eds). Leatherhead Publishing: Leatherhead, 2000; 237.
16. Kim H, Xia H, Li L. Gewin J. Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy. Biofactors 2000; 12: 243.
17. Chiechi L, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 2002; 42: 295.
18. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of oestrogen receptors alpha and beta. Endocrinology 1997; 138: 863.
19. Wilson T, March H, Ban WJ, Hou Y, Adler S, Meyers CY, Winters TA, Maher MA. Antioxidant effects of phyto-and synthetic-estrogens on cupric ion-induced oxidation of human low-density lipoproteins in vitro. Life Sci. 2002; 70: 2287.
20. Kerry N, Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 1998; 140: 341.
21. Boersma BJ, Patel RP, Kirk M, Jackson PL, Muccio D, Darley-Usmar VM, Barnes S. Chlorination and nitration of soy isoflavones. Arch. Biochem. Biophys. 1999; 368: 265.
22. Boersma BJ, Barnes S, Kirk M, Wang CC, Smith M, Kim H, Xu J, Patel R, Darley-Usmar VM. Soy isoflavonoids and cancer-metabolism at the target site. Mutat. Res. 2001; 480-481: 121.
23. Boersma BJ, Patel RP, Botting N, White CR, Parks D, Barnes S, Darley-Usmar VM. Formation of novel bioactive metabolites from the reactions of pro-inflammatory oxidants with polyphenolics. Biofactors 2001; 15: 79.
24. Peterson TG, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 1991; 179: 661.
25. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr. 2002; 132: 552S.
26. Clarkson TB, Anthony MS. Phytoestrogens and coronary heart disease. Baillieres Clin. Endocrinol. Metab. 1998; 12: 589.
27. Barnes S, Wang CC, Kirk M, Smith-Johnson M, Coward L, Barnes NC, Vance G, Boersma B. HPLC-mass spectrometry of isoflavonoids; in soy and the American groundnut, Apios americana. Adv. Exp. Med. Biol. 2002; 505: 77.
28. McLafferty FW. In Interpretation of Mass Spectra, Turecek F (ed.). University Science Books: Mill Valley, CA, 1993; 278.
29. Domingues MRM, S-Marques MG, Domingues P, Neves MG, Cavalerio JAS, Ferrer-Correria AJ, Nemirovsky OV, Gross ML. Differentiation of positional isomers of nitro mesotetraphenylporphyrins by tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 2001; 12: 381.
30. Binsack R, Boersma BJ, Patel RP, Kirk M, White CR, Darley-Usmar V, Barnes S, Zhou F, Parks DA. Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid. Alcohol. Clin. Exp. Res. 2001; 25: 434.